That's been my thinking as well. It's possible Dr. B may be one of the future trial investigators but I doubt much more than that. He'll be pretty busy as it is coordinating the pipeline. Getting the right companies to work the science and trials has only just begun with the selection of Alfa.

THERE's A LOT more coming over the short term (couple months) to even longer term. Each deal further solidifies IPIX as a company and its fundamentals. Looking forward to watching IPIX bloom.